Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis

Molecular and Cellular Biology

Volumn 33, Issue 22, 2013, Pages 4606-4617

  Liu, Yang ^a,b   Zhang, Ya Dong ^a   Guo, Liang ^a   Huang, Hai Yan ^a,b   Zhu, Hao ^a,b   Huang, Jia Xin ^a   Liu, Yuan ^a,b   Zhou, Shui Rong ^a   Dang, Yong Jun ^a   Li, Xi ^a,b   Tang, Qi Qun ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT1; SUMO 3 PROTEIN; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; IN VIVO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; RNA INTERFERENCE; SUMOYLATION; UBIQUITINATION;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN STABILITY; PROTEOLYSIS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84887007913     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00723-13     Document Type: Article

References (50)

1. Haslam DW, James WP. 2005. Obesity. Lancet 366:1197-1209.
2. Hirsch J, Batchelor B. 1976. Adipose tissue cellularity in human obesity. Clin. Endocrinol. Metab. 5:299-311.
3. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB. 1993. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J. Biol. Chem. 268: 22243-22246.
4. Green H, Kehinde O. 1975. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:19-27.
5. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM. 1996. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev. 10:974-984.
6. Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD, Nakabeppu Y, Kelly TJ, Lane MD. 1989. Differentiationinduced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev. 3:1323-1335.
7. MacDougald OA, Lane MD. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64: 345-373.
8. Tang QQ, Lane MD. 2012. Adipogenesis: from stem cell to adipocyte. Annu. Rev. Biochem. 81:715-736.
9. Schwarz EJ, Reginato MJ, Shao D, Krakow SL, Lazar MA. 1997. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription. Mol. Cell. Biol. 17:1552-1561.
10. Tanaka T, Yoshida N, Kishimoto T, Akira S. 1997. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 16:7432-7443.
11. Dingwall M, Marchildon F, Gunanayagam A, Louis CS, Wiper-Bergeron N. 2011. Retinoic acid-induced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells. Differentiation 82:57-65.
12. Marchildon F, Lala N, Li G, St-Louis C, Lamothe D, Keller C, Wiper-Bergeron N. 2012. CCAAT/enhancer binding protein beta is expressed in satellite cells and controls myogenesis. Stem Cells 30:2619-2630.
13. Li X, Kim JW, Gronborg M, Urlaub H, Lane MD, Tang QQ. 2007. Role of cdk2 in the sequential phosphorylation/activation of C/EBPbeta during adipocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 104:11597-11602.
14. Tang QQ, Gronborg M, Huang H, Kim JW, Otto TC, Pandey A, Lane MD. 2005. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 102:9766-9771.
15. Guo L, Li X, Huang JX, Huang HY, Zhang YY, Qian SW, Zhu H, Zhang YD, Liu Y, Wang KK, Tang QQ. 2012. Histone demethylase Kdm4b functions as a co-factor of C/EBPbeta to promote mitotic clonal expansion during differentiation of 3T3-L1 preadipocytes. Cell Death Differ. 19:1917-1927.
16. Tang QQ, Lane MD. 1999. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev. 13:2231-2241.
17. Tang QQ, Otto TC, Lane MD. 2003. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 100:44-49.
18. Li X, Molina H, Huang H, Zhang YY, Liu M, Qian SW, Slawson C, Dias WB, Pandey A, Hart GW, Lane MD, Tang QQ. 2009. O-linked Nacetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation. J. Biol. Chem. 284:19248- 19254.
19. Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, Spiegelman BM. 2009. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 460:1154-1158.
20. Eaton EM, Sealy L. 2003. Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 278:33416-33421.
21. Mukhopadhyay D, Dasso M. 2007. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32:286-295.
22. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK. 2005. A SUMOylationdependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437:759-763.
23. Yeh ET. 2009. SUMOylation and de-SUMOylation: wrestling with life's processes. J. Biol. Chem. 284:8223-8227.
24. Johnson ES. 2004. Protein modification by SUMO. Annu. Rev. Biochem. 73:355-382.
25. Geiss-Friedlander R, Melchior F. 2007. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8:947-956.
26. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K. 1997. Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803-1805.
27. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K. 1998. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. U. S. A. 95:10626-10631.
28. Rytinki MM, Kaikkonen S, Pehkonen P, Jaaskelainen T, Palvimo JJ. 2009. PIAS proteins: pleiotropic interactors associated with SUMO. Cell. Mol. Life Sci. 66:3029-3041.
29. Hoefer J, Schafer G, Klocker H, Erb HH, Mills IG, Hengst L, Puhr M, Culig Z. 2012. PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21. Am. J. Pathol. 180:2097-2107.
30. Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, Jackson SP. 2009. MammalianSUMOE3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 462:935-939.
31. Liu B, Shuai K. 2008. Targeting the PIAS1 SUMO ligase pathway to control inflammation. Trends Pharmacol. Sci. 29:505-509.
32. Chung SS, Ahn BY, Kim M, Choi HH, Park HS, Kang S, Park SG, Kim YB, Cho YM, Lee HK, Chung CH, Park KS. 2010. Control of adipogenesis by the SUMO-specific protease SENP2. Mol. Cell. Biol. 30:2135-2146.
33. Hattori T, Ohoka N, Inoue Y, Hayashi H, Onozaki K. 2003. C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer. Oncogene 22:1273-1280.
34. Musri MM, Parrizas M. 2012. Epigenetic regulation of adipogenesis. Curr. Opin. Clin. Nutr. Metab. Care 15:342-349.
35. Siersbæk R, Nielsen R, John S, Sung MH, Baek S, Loft A, Hager GL, Mandrup S. 2011. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 30: 1459-1472.
36. Steger DJ, Grant GR, Schupp M, Tomaru T, Lefterova MI, Schug J, Manduchi E, Stoeckert CJ, Jr, Lazar MA. 2010. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 24:1035- 1044.
37. Tang QQ, Lane MD. 2000. Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding proteinbeta during adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 97:12446-12450.
38. Bezy O, Vernochet C, Gesta S, Farmer SR, Kahn CR. 2007. TRB3 blocks adipocyte differentiation through the inhibition of C/EBPbeta transcriptional activity. Mol. Cell. Biol. 27:6818-6831.
39. Subramanian L, Benson MD, Iniguez-Lluhi JA. 2003. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J. Biol. Chem. 278:9134-9141.
40. Ohshima T, Koga H, Shimotohno K. 2004. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification. J. Biol. Chem. 279:29551-29557.
41. Kotaja N, Karvonen U, Janne OA, Palvimo JJ. 2002. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22:5222-5234.
42. Liu B, Yang Y, Chernishof V, Loo RR, Jang H, Tahk S, Yang R, Mink S, Shultz D, Bellone CJ, Loo JA, Shuai K. 2007. Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell 129:903-914.
43. Zhang Y, Gan Z, Huang P, Zhou L, Mao T, Shao M, Jiang X, Chen Y, Ying H, Cao M, Li J, Zhang WJ, Yang L, Liu Y. 2012. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors. J. Biol. Chem. 287:37973-37985.
44. Palvimo JJ. 2007. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem. Soc. Trans. 35:1405-1408.
45. Aravind L, Koonin EV. 2000. SAP-a putative DNA-binding motif involved in chromosomal organization. Trends Biochem. Sci. 25:112-114.
46. Liu B, Tahk S, Yee KM, Fan G, Shuai K. 2010. The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science 330:521-525.
47. Ying HY, Su ST, Hsu PH, Chang CC, Lin IY, Tseng YH, Tsai MD, Shih HM, Lin KI. 2012. SUMOylation of Blimp-1 is critical for plasma cell differentiation. EMBO Rep. 13:631-637.
48. Diao Y, Wang X, Wu Z. 2009. SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factorinduced JAK1/STAT1/STAT3 pathway. Mol. Cell. Biol. 29:5084-5093.
49. Kawai-Kowase K, Kumar MS, Hoofnagle MH, Yoshida T, Owens GK. 2005. PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. Mol. Cell. Biol. 25:8009-8023.
50. Lee H, Quinn JC, Prasanth KV, Swiss VA, Economides KD, Camacho MM, Spector DL, Abate-Shen C. 2006. PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev. 20:784-794.